Thomas D. Coates

Hematology | Oncology

4650 W Sunset Blvd # 54
Los Angeles, CA 90027

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 166 publications

Chronic Anemia Is Associated With Subclinical Myocardial Fibrosis in α-Τhalassemia Intermedia.

Chronic Anemia Is Associated With Subclinical Myocardial Fibrosis in α-Τhalassemia Intermedia.

Journal: American journal of hematology

Published: August 01, 2026

A Community-Based Intervention to Increase PrEP Initiation and Reduce Internalized Stigma: A Randomized Trial Among Black Sexual Minority Men in Prince George's County, Maryland.

A Community-Based Intervention to Increase PrEP Initiation and Reduce Internalized Stigma: A Randomized Trial Among Black Sexual Minority Men in Prince George's County, Maryland.

Journal: AIDS patient care and STDs

Published: July 29, 2026

Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait.

Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait.

Journal: American journal of hematology

Published: May 14, 2026

Chronic Anemia Patients Demonstrate Diffuse Demyelination.

Chronic Anemia Patients Demonstrate Diffuse Demyelination.

Journal: American journal of hematology

Published: April 29, 2026

Male partner involvement in pregnant and breastfeeding women's use of pre-exposure prophylaxis (PrEP) in a low-income setting in South Africa.

Male partner involvement in pregnant and breastfeeding women's use of pre-exposure prophylaxis (PrEP) in a low-income setting in South Africa.

Journal: Research square

Published: February 06, 2026

Addressing Obstetric and Gynecologic Needs in Thalassemia.

Addressing Obstetric and Gynecologic Needs in Thalassemia.

Journal: O&G open

Published: January 08, 2026

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances

Published: December 19, 2025

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances

Published: December 19, 2025

From treatment to biology and back: managing iron overload in transfused hemoglobinopathies.

From treatment to biology and back: managing iron overload in transfused hemoglobinopathies.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Exploration of Pregnant and Breastfeeding Women's Acceptability of Rapid Point-of-Care Urine Testing Within Antenatal and Postnatal Care, and Its Perceived Impact on PrEP Adherence When Paired with PrEP Biofeedback Adherence Counselling in Cape Town, South Africa.

Exploration of Pregnant and Breastfeeding Women's Acceptability of Rapid Point-of-Care Urine Testing Within Antenatal and Postnatal Care, and Its Perceived Impact on PrEP Adherence When Paired with PrEP Biofeedback Adherence Counselling in Cape Town, South Africa.

Journal: AIDS and behavior

Published: October 25, 2025

Early Detection of Diastolic Dysfunction in Sickle Cell Anemia: Can It Help the Patient and Let Us See the Elephant in the Room?

Early Detection of Diastolic Dysfunction in Sickle Cell Anemia: Can It Help the Patient and Let Us See the Elephant in the Room?

Journal: American journal of hematology

Published: July 08, 2025

Wearable Device Photoplethysmography As a Viable Tool to Longitudinally Monitor Vasoconstriction Biomarkers for Predicting Vaso-Occlusive Crisis in Sickle Cell Disease: Feasibility and Validation Study.

Wearable Device Photoplethysmography As a Viable Tool to Longitudinally Monitor Vasoconstriction Biomarkers for Predicting Vaso-Occlusive Crisis in Sickle Cell Disease: Feasibility and Validation Study.

Journal: JMIR human factors

Published: April 03, 2025

Showing 1-12 of 166

Last Updated: 09/26/2026